2,4-二氯-5-氰基噻唑 | 82554-18-5

• 物质功能分类: 有机原料 - 杂环化合物
• 分子结构分类: 有机化合物 - 有机杂环化合物 - 唑类
• 中文名称: 2,4-二氯-5-氰基噻唑
• 英文名称: 2,4-dichlorothiazole-5-carbonitrile
• 英文别名: 2,4-Dichloro-5-cyanothiazole；2,4-dichloro-1,3-thiazole-5-carbonitrile
• CAS: 82554-18-5
• 化学式: C₄Cl₂N₂S
• mdl: MFCD08669569
• 分子量: 179.029
• InChiKey: HXWDCGDBOAECIP-UHFFFAOYSA-N

物化性质

• 沸点：
  339.1±45.0 °C(Predicted)
• 密度：
  1.70±0.1 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  2.9
• 重原子数：
  9
• 可旋转键数：
  0
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.0
• 拓扑面积：
  64.9
• 氢给体数：
  0
• 氢受体数：
  3

安全信息

• 海关编码：
  2934100090
• 危险性防范说明：
  P261,P280,P305+P351+P338
• 危险性描述：
  H302,H315,H319,H332,H335
• 储存条件：
  2-8°C

SDS

Material Safety Data Sheet

---

Section 1. Identification of the substance
Product Name: 2,4-Dichloro-5-cyanothiazole
Synonyms:

---

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.

---

Section 3. Composition/information on ingredients.
Ingredient name: 2,4-Dichloro-5-cyanothiazole
CAS number: 82554-18-5

---

Section 4. First aid measures
Skin contact: Immediately wash skin with copious amounts of water for at least 15 minutes while removing
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Ingestion: Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.

---

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

---

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

---

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Store in closed vessels, refrigerated.
Storage:

---

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

---

Section 9. Physical and chemical properties
Appearance: Not specified
Boiling point: No data
No data
Melting point:
Flash point: No data
Density: No data
Molecular formula: C4Cl2N2S
Molecular weight: 179.0

---

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide, nitrogen oxides, hydrogen chloride, sulfur oxides.

---

Section 11. Toxicological information
No data.

---

Section 12. Ecological information
No data.

---

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

---

Section 14. Transportation information
Non-harzardous for air and ground transportation.

---

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

反应信息

• 作为反应物：
  描述：

  2,4-二氯-5-氰基噻唑 在 溶剂黄146 、 锌 作用下， 以69%的产率得到4-氯-1,3-噻唑-5-甲腈
  参考文献：
  名称：

  [EN] PYRIMIDINONE DERIVATIVES AS CDC7 INHIBITORS
  [FR] DÉRIVÉS DE PYRIMIDINONE EN TANT QU'INHIBITEURS DE CDC7

  摘要：

  本发明涉及根据本文所定义的式I的化合物，以及其盐和溶剂合物，其作为细胞分裂周期7（Cdc7）激酶酶活性的抑制剂。本发明还涉及包含它们的药物组合物，以及它们在治疗增殖性疾病（如癌症）以及其他涉及Cdc7激酶活性的疾病或病况中的用途。

  公开号：

  WO2018087527A1
• 作为产物：
  描述：

  (E)-1-(2,4-二氯-1,3-噻唑-5-基)-N-羟基甲亚胺 在 2,4-二氯-5-氰基噻唑 、 petroleum ether 作用下， 以 乙酸酐 为溶剂， 反应 4.0h， 生成 2,4-二氯-5-氰基噻唑
  参考文献：
  名称：

  2,4-Dichloro-5-thiazolecarboxaldehyde and a process for its preparation

  摘要：

  公式为##STR1##的新2,4-二氯-5-噻唑羧醛可以通过将2,4-噻唑烷二酮（III）与1-1.5摩尔二甲基甲酰胺和3-10摩尔氧化亚磷酰在反应混合物的沸点（约115℃）下反应，直到HCl气体的产生结束，然后进行水解反应，可以得到良好的产率。醛（II）可以通过新的肟（IV）转化为相应的腈，2,4-二氯-5-氰基噻唑（V），这是制备噻唑氧乙酰胺类除草剂活性化合物的已知中间体。

  公开号：

  US04555577A1
• 作为试剂：
  描述：

  (E)-1-(2,4-二氯-1,3-噻唑-5-基)-N-羟基甲亚胺 在 2,4-二氯-5-氰基噻唑 、 petroleum ether 作用下， 以 乙酸酐 为溶剂， 反应 4.0h， 生成 2,4-二氯-5-氰基噻唑
  参考文献：
  名称：

  2,4-Dichloro-5-thiazolecarboxaldehyde and a process for its preparation

  摘要：

  公式为##STR1##的新2,4-二氯-5-噻唑羧醛可以通过将2,4-噻唑烷二酮（III）与1-1.5摩尔二甲基甲酰胺和3-10摩尔氧化亚磷酰在反应混合物的沸点（约115℃）下反应，直到HCl气体的产生结束，然后进行水解反应，可以得到良好的产率。醛（II）可以通过新的肟（IV）转化为相应的腈，2,4-二氯-5-氰基噻唑（V），这是制备噻唑氧乙酰胺类除草剂活性化合物的已知中间体。

  公开号：

  US04555577A1

文献信息

• [EN] CARBOXAMIDES AS UBIQUITIN-SPECIFIC PROTEASE INHIBITORS<br/>[FR] CARBOXAMIDES UTILISÉES EN TANT QU'INHIBITEURS DE PROTÉASE SPÉCIFIQUE DE L'UBIQUITINE
  申请人：FORMA THERAPEUTICS INC

  公开号：WO2019032863A1

  公开（公告）日：2019-02-14

  The present disclosure relates to modulators, such as inhibitors, of at least one pathway chosen from USP28 and USP25, pharmaceutical compositions comprising the inhibitors, and methods of using the inhibitors. The modulators, such as inhibitors, of at least one pathway chosen from USP28 and USP25 can be useful in the treatment of cancers, among other ailments.

  本公开涉及调节剂，如抑制剂，至少选择自USP28和USP25中的一条途径的药物组合物包括这些抑制剂，以及使用这些抑制剂的方法。这些调节剂，如抑制剂，至少选择自USP28和USP25中的一条途径，可用于治疗癌症等疾病。
• Azoles. Part 10. Thiazolo[4′,5′,4,5]thieno[3,2-d]pyrimidine, a New Heterocyclic Ring System
  作者：Salah Athmani、Brian Iddon

  DOI：10.1016/s0040-4020(01)90380-1

  日期：1992.9

  obtained were converted into the corresponding thiazolo[4′,5′;4,5]thieno[3,2-d]pyrimidin-5(6H)-one by treatment with triethyl orthoformate in acetic anhydride. With phosphoryl chloride these gave the 5-chloro-derivative, which underwent displacement of the chlorine-atom when allowed to react with various amines. Reductive dechlorination of 5-chlorothiazolo[4′,5′;4,5]thieno[3,2-d]-pyrimidine gave the parent

  通过使4-氯噻唑-5-甲醛或4-氯噻唑-5-腈与2-巯基乙酸乙酯或2-巯基乙酰胺反应来制备噻吩并[2,3- d ]噻唑。将获得的6-氨基噻吩并[2,3- d ]噻唑-5-羧酰胺转化为相应的噻唑并[4'，5'; 4,5]噻吩并[3,2 - d ]嘧啶-5（6 H）-一种通过在乙酸酐中用原甲酸三乙酯处理。用磷酰氯得到5-氯衍生物，当其与各种胺反应时，该氯原子被氯原子取代。5-氯噻唑并[4'，5'; 4,5]噻吩并[3,2- d ]-嘧啶的还原脱氯反应得到母体杂环。
• [EN] SMALL MOLECULE INHIBITORS OF NF-KB INDUCING KINASE<br/>[FR] INHIBITEURS À PETITES MOLÉCULES DE KINASE INDUISANT NF-KB
  申请人：JANSSEN PHARMACEUTICA NV

  公开号：WO2022104348A1

  公开（公告）日：2022-05-19

  This invention relates to compounds of Formula I that inhibit NIK and pharmaceutical compositions comprising such compounds and methods of using the same. These compounds and pharmaceutical compositions are useful for preventing or treating diseases such as cancer (such as B-cell malignancies including leukemias, lymphomas and myeloma), inflammatory disorders, autoimmune disorders, immunodermatologic disorders such as palmoplantar pustulosis and hidradenitis suppurativa, and metabolic disorders such as obesity and diabetes.

  本发明涉及公式I的化合物，其抑制NIK，以及包含这种化合物的制药组合物和使用它们的方法。这些化合物和制药组合物有助于预防或治疗癌症（如B细胞恶性肿瘤，包括白血病，淋巴瘤和骨髓瘤），炎症性疾病，自身免疫性疾病，免疫性皮肤病，如掌跖症和汗腺炎，以及代谢性疾病，如肥胖和糖尿病。
• Heteroaryls and uses thereof
  申请人：Cardin David P.

  公开号：US20100075951A1

  公开（公告）日：2010-03-25

  This invention provides compounds of formula I: wherein R 1 , R 2 , CY, Y 1 , Y 2 , X 1 , X 2 , and X 3 are as described in the specification. The compounds are inhibitors of PI3K and are thus useful for treating proliferative, inflammatory, or cardiovascular disorders.

  本发明提供了式I的化合物：其中R1、R2、CY、Y1、Y2、X1、X2和X3如说明书所述。这些化合物是PI3K的抑制剂，因此用于治疗增殖性、炎症性或心血管疾病。
• HETEROARYLS AND USES THEREOF
  申请人：Cardin David P.

  公开号：US20120202812A1

  公开（公告）日：2012-08-09

  This invention provides compounds of formula I: wherein R 1 , R 2 , CY, Y 1 , Y 2 , X 1 , X 2 , and X 3 are as described in the specification. The compounds are inhibitors of PI3K and are thus useful for treating proliferative, inflammatory, or cardiovascular disorders.

  本发明提供了式I的化合物：其中R1，R2，CY，Y1，Y2，X1，X2和X3如规范中所述。这些化合物是PI3K的抑制剂，因此可用于治疗增殖性、炎症性或心血管疾病。